• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌及头颈部鳞状细胞癌:分子特征的新见解

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization.

作者信息

Polo Valentina, Pasello Giulia, Frega Stefano, Favaretto Adolfo, Koussis Haralabos, Conte Pierfranco, Bonanno Laura

机构信息

Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.

Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.

出版信息

Oncotarget. 2016 May 3;7(18):25050-63. doi: 10.18632/oncotarget.7732.

DOI:10.18632/oncotarget.7732
PMID:26933818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5041888/
Abstract

Squamous cell carcinomas of the lung and of the head and neck district share strong association with smoking habits and are characterized by smoke-related genetic alterations. Driver mutations have been identified in small percentage of lung squamous cell carcinoma. In parallel, squamous head and neck tumors are classified according to the HPV positivity, thus identifying two different clinical and molecular subgroups of disease.This review depicts different molecular portraits and potential clinical application in the field of targeted therapy, immunotherapy and chemotherapy personalization.

摘要

肺癌以及头颈部区域的鳞状细胞癌都与吸烟习惯密切相关,并且具有与吸烟相关的基因改变特征。在一小部分肺鳞状细胞癌中已鉴定出驱动突变。与此同时,头颈部鳞状肿瘤根据人乳头瘤病毒(HPV)的阳性情况进行分类,从而确定了该疾病的两个不同临床和分子亚组。本综述描绘了不同的分子特征以及在靶向治疗、免疫治疗和化疗个体化领域的潜在临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7531/5041888/8b64dd322bf2/oncotarget-07-25050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7531/5041888/c98bf44439e8/oncotarget-07-25050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7531/5041888/8b64dd322bf2/oncotarget-07-25050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7531/5041888/c98bf44439e8/oncotarget-07-25050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7531/5041888/8b64dd322bf2/oncotarget-07-25050-g002.jpg

相似文献

1
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization.肺癌及头颈部鳞状细胞癌:分子特征的新见解
Oncotarget. 2016 May 3;7(18):25050-63. doi: 10.18632/oncotarget.7732.
2
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.TRAF3/CYLD突变可鉴定出人类乳头瘤病毒相关头颈部鳞状细胞癌的一个独特亚群。
Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13.
3
[Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].[头颈部鳞状细胞癌的基因组特征:对治疗管理的影响与挑战]
Bull Cancer. 2018 Sep;105(9):820-829. doi: 10.1016/j.bulcan.2018.05.011. Epub 2018 Jun 22.
4
A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus.一部分腮腺原发性鳞状细胞癌携带高危型人乳头瘤病毒。
Histopathology. 2016 Dec;69(6):921-929. doi: 10.1111/his.13027. Epub 2016 Aug 23.
5
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.头颈部鳞状细胞癌基因组研究的治疗见解
Cancer Discov. 2015 Mar;5(3):239-44. doi: 10.1158/2159-8290.CD-14-1205. Epub 2015 Feb 2.
6
Human papillomavirus and gene mutations in head and neck squamous carcinomas.人乳头瘤病毒与头颈部鳞状细胞癌中的基因突变
ANZ J Surg. 2012 May;82(5):362-6. doi: 10.1111/j.1445-2197.2011.05791.x. Epub 2011 May 19.
7
DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.头颈部鳞状细胞癌中人类乳头瘤病毒的检测:文献综述
Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):502-9.
8
Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.人乳头瘤病毒相关头颈部癌的基因图谱及其与烟草相关肿瘤的比较。
J Clin Oncol. 2015 Oct 10;33(29):3227-34. doi: 10.1200/JCO.2015.62.1086. Epub 2015 Sep 8.
9
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.对头颈部局部晚期鳞状细胞癌进行靶向二代测序可揭示用于改善辅助放化疗的可用药靶点。
Eur J Cancer. 2016 Apr;57:78-86. doi: 10.1016/j.ejca.2016.01.003. Epub 2016 Feb 18.
10
Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.头颈部鳞状细胞癌的病因异质性:人乳头瘤病毒感染、吸烟和饮酒的作用
Carcinogenesis. 2017 Dec 7;38(12):1188-1195. doi: 10.1093/carcin/bgx106.

引用本文的文献

1
Immunohistochemistry for Skin Cancers: A Comprehensive Approach to the Diagnosis of Squamous Cell Carcinoma.皮肤癌的免疫组织化学:鳞状细胞癌诊断的综合方法
Cancers (Basel). 2025 May 12;17(10):1629. doi: 10.3390/cancers17101629.
2
Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.隐匿于众目睽睽之下:NUT癌是一种未被识别的肺及头颈部鳞状细胞癌亚型。
Nat Rev Clin Oncol. 2025 Apr;22(4):292-306. doi: 10.1038/s41571-025-00986-3. Epub 2025 Feb 3.
3
Deciphering the role of claudins in lung cancer.

本文引用的文献

1
Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.靶向不可成药靶点:免疫疗法在基因组时代与个性化肿瘤学相遇。
Ann Oncol. 2015 Dec;26(12):2367-74. doi: 10.1093/annonc/mdv382. Epub 2015 Sep 14.
2
Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.复发性或转移性头颈部鳞状细胞癌的当前治疗选择。
J Clin Oncol. 2015 Oct 10;33(29):3305-13. doi: 10.1200/JCO.2015.62.0963. Epub 2015 Sep 8.
3
Detection of human papillomavirus in non-small cell carcinoma of the lung.
解读紧密连接蛋白在肺癌中的作用。
Front Oncol. 2024 Sep 19;14:1435535. doi: 10.3389/fonc.2024.1435535. eCollection 2024.
4
Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression.通过 DNA 甲基化与基因表达的关系来阐明癌症亚型。
Genes (Basel). 2024 May 16;15(5):631. doi: 10.3390/genes15050631.
5
Combined Atezolizumab and Chemotherapy for a Patient With Double Primary Cancers.阿替利珠单抗联合化疗治疗双原发癌患者
In Vivo. 2020 Jan-Feb;34(1):389-392. doi: 10.21873/invivo.11785.
6
Somatic genome alterations in relation to age in lung squamous cell carcinoma.肺鳞状细胞癌中与年龄相关的体细胞基因组改变
Oncotarget. 2018 Aug 14;9(63):32161-32172. doi: 10.18632/oncotarget.25848.
肺非小细胞癌中人乳头瘤病毒的检测
Hum Pathol. 2015 Nov;46(11):1592-7. doi: 10.1016/j.humpath.2015.07.012. Epub 2015 Jul 29.
4
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.阿法替尼对比厄洛替尼二线治疗晚期肺鳞癌患者(LUX-Lung 8):一项开放标签、随机对照、III 期临床研究。
Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5.
5
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.癌症治疗的免疫检查点阻断:重焕受抑制免疫系统的活力。
Trends Mol Med. 2015 Aug;21(8):482-91. doi: 10.1016/j.molmed.2015.05.005. Epub 2015 Jun 16.
6
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.耐昔妥珠单抗联合吉西他滨和顺铂与吉西他滨和顺铂单药一线治疗局部晚期或转移性鳞状非小细胞肺癌患者(SQUIRE):一项开放标签、随机、对照的 3 期临床试验。
Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1.
7
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.鳞状特性:新一代测序揭示了跨鳞状肿瘤类型的共同分子特征。
Cell Cycle. 2015;14(14):2355-61. doi: 10.1080/15384101.2015.1053669. Epub 2015 Jun 1.
8
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.纳武单抗与多西他赛治疗晚期鳞状细胞非小细胞肺癌的疗效比较
N Engl J Med. 2015 Jul 9;373(2):123-35. doi: 10.1056/NEJMoa1504627. Epub 2015 May 31.
9
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
10
Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma.靶向头颈部鳞状细胞癌中的PI3K信号通路
Am Soc Clin Oncol Educ Book. 2015:123-8. doi: 10.14694/EdBook_AM.2015.35.123.